1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Prostate Cancer Screening Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Physical Exam 1.2.3 Laboratory Tests 1.2.4 Imaging Tests 1.2.5 Gleason Score 1.2.6 TNM Score 1.2.7 Genetic Tests 1.2.8 Digital Rectal Exam 1.2.9 Biopsy 1.3 Market by Application 1.3.1 Global Prostate Cancer Screening Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Research Labs 1.3.5 Cancer Institutes 1.3.6 Diagnostic Centers 1.3.7 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Prostate Cancer Screening Market Perspective (2016-2027) 2.2 Prostate Cancer Screening Growth Trends by Regions 2.2.1 Prostate Cancer Screening Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Prostate Cancer Screening Historic Market Share by Regions (2016-2021) 2.2.3 Prostate Cancer Screening Forecasted Market Size by Regions (2022-2027) 2.3 Prostate Cancer Screening Industry Dynamic 2.3.1 Prostate Cancer Screening Market Trends 2.3.2 Prostate Cancer Screening Market Drivers 2.3.3 Prostate Cancer Screening Market Challenges 2.3.4 Prostate Cancer Screening Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Prostate Cancer Screening Players by Revenue 3.1.1 Global Top Prostate Cancer Screening Players by Revenue (2016-2021) 3.1.2 Global Prostate Cancer Screening Revenue Market Share by Players (2016-2021) 3.2 Global Prostate Cancer Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Prostate Cancer Screening Revenue 3.4 Global Prostate Cancer Screening Market Concentration Ratio 3.4.1 Global Prostate Cancer Screening Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Screening Revenue in 2020 3.5 Prostate Cancer Screening Key Players Head office and Area Served 3.6 Key Players Prostate Cancer Screening Product Solution and Service 3.7 Date of Enter into Prostate Cancer Screening Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Prostate Cancer Screening Breakdown Data by Type 4.1 Global Prostate Cancer Screening Historic Market Size by Type (2016-2021) 4.2 Global Prostate Cancer Screening Forecasted Market Size by Type (2022-2027) 5 Prostate Cancer Screening Breakdown Data by Application 5.1 Global Prostate Cancer Screening Historic Market Size by Application (2016-2021) 5.2 Global Prostate Cancer Screening Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Prostate Cancer Screening Market Size (2016-2027) 6.2 North America Prostate Cancer Screening Market Size by Type 6.2.1 North America Prostate Cancer Screening Market Size by Type (2016-2021) 6.2.2 North America Prostate Cancer Screening Market Size by Type (2022-2027) 6.2.3 North America Prostate Cancer Screening Market Size by Type (2016-2027) 6.3 North America Prostate Cancer Screening Market Size by Application 6.3.1 North America Prostate Cancer Screening Market Size by Application (2016-2021) 6.3.2 North America Prostate Cancer Screening Market Size by Application (2022-2027) 6.3.3 North America Prostate Cancer Screening Market Size by Application (2016-2027) 6.4 North America Prostate Cancer Screening Market Size by Country 6.4.1 North America Prostate Cancer Screening Market Size by Country (2016-2021) 6.4.2 North America Prostate Cancer Screening Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Prostate Cancer Screening Market Size (2016-2027) 7.2 Europe Prostate Cancer Screening Market Size by Type 7.2.1 Europe Prostate Cancer Screening Market Size by Type (2016-2021) 7.2.2 Europe Prostate Cancer Screening Market Size by Type (2022-2027) 7.2.3 Europe Prostate Cancer Screening Market Size by Type (2016-2027) 7.3 Europe Prostate Cancer Screening Market Size by Application 7.3.1 Europe Prostate Cancer Screening Market Size by Application (2016-2021) 7.3.2 Europe Prostate Cancer Screening Market Size by Application (2022-2027) 7.3.3 Europe Prostate Cancer Screening Market Size by Application (2016-2027) 7.4 Europe Prostate Cancer Screening Market Size by Country 7.4.1 Europe Prostate Cancer Screening Market Size by Country (2016-2021) 7.4.2 Europe Prostate Cancer Screening Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Prostate Cancer Screening Market Size (2016-2027) 8.2 Asia-Pacific Prostate Cancer Screening Market Size by Type 8.2.1 Asia-Pacific Prostate Cancer Screening Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Prostate Cancer Screening Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Prostate Cancer Screening Market Size by Type (2016-2027) 8.3 Asia-Pacific Prostate Cancer Screening Market Size by Application 8.3.1 Asia-Pacific Prostate Cancer Screening Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Prostate Cancer Screening Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Prostate Cancer Screening Market Size by Application (2016-2027) 8.4 Asia-Pacific Prostate Cancer Screening Market Size by Region 8.4.1 Asia-Pacific Prostate Cancer Screening Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Prostate Cancer Screening Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Prostate Cancer Screening Market Size (2016-2027) 9.2 Latin America Prostate Cancer Screening Market Size by Type 9.2.1 Latin America Prostate Cancer Screening Market Size by Type (2016-2021) 9.2.2 Latin America Prostate Cancer Screening Market Size by Type (2022-2027) 9.2.3 Latin America Prostate Cancer Screening Market Size by Type (2016-2027) 9.3 Latin America Prostate Cancer Screening Market Size by Application 9.3.1 Latin America Prostate Cancer Screening Market Size by Application (2016-2021) 9.3.2 Latin America Prostate Cancer Screening Market Size by Application (2022-2027) 9.3.3 Latin America Prostate Cancer Screening Market Size by Application (2016-2027) 9.4 Latin America Prostate Cancer Screening Market Size by Country 9.4.1 Latin America Prostate Cancer Screening Market Size by Country (2016-2021) 9.4.2 Latin America Prostate Cancer Screening Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Prostate Cancer Screening Market Size (2016-2027) 10.2 Middle East & Africa Prostate Cancer Screening Market Size by Type 10.2.1 Middle East & Africa Prostate Cancer Screening Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Prostate Cancer Screening Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Prostate Cancer Screening Market Size by Type (2016-2027) 10.3 Middle East & Africa Prostate Cancer Screening Market Size by Application 10.3.1 Middle East & Africa Prostate Cancer Screening Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Prostate Cancer Screening Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Prostate Cancer Screening Market Size by Application (2016-2027) 10.4 Middle East & Africa Prostate Cancer Screening Market Size by Country 10.4.1 Middle East & Africa Prostate Cancer Screening Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Prostate Cancer Screening Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Abbott Laboratories 11.1.1 Abbott Laboratories Company Details 11.1.2 Abbott Laboratories Business Overview 11.1.3 Abbott Laboratories Prostate Cancer Screening Introduction 11.1.4 Abbott Laboratories Revenue in Prostate Cancer Screening Business (2016-2021) 11.1.5 Abbott Laboratories Recent Development 11.2 Almac 11.2.1 Almac Company Details 11.2.2 Almac Business Overview 11.2.3 Almac Prostate Cancer Screening Introduction 11.2.4 Almac Revenue in Prostate Cancer Screening Business (2016-2021) 11.2.5 Almac Recent Development 11.3 Bayer 11.3.1 Bayer Company Details 11.3.2 Bayer Business Overview 11.3.3 Bayer Prostate Cancer Screening Introduction 11.3.4 Bayer Revenue in Prostate Cancer Screening Business (2016-2021) 11.3.5 Bayer Recent Development 11.4 Beckman Coulter 11.4.1 Beckman Coulter Company Details 11.4.2 Beckman Coulter Business Overview 11.4.3 Beckman Coulter Prostate Cancer Screening Introduction 11.4.4 Beckman Coulter Revenue in Prostate Cancer Screening Business (2016-2021) 11.4.5 Beckman Coulter Recent Development 11.5 BioméRieux 11.5.1 BioméRieux Company Details 11.5.2 BioméRieux Business Overview 11.5.3 BioméRieux Prostate Cancer Screening Introduction 11.5.4 BioméRieux Revenue in Prostate Cancer Screening Business (2016-2021) 11.5.5 BioméRieux Recent Development 11.6 Genomic Health 11.6.1 Genomic Health Company Details 11.6.2 Genomic Health Business Overview 11.6.3 Genomic Health Prostate Cancer Screening Introduction 11.6.4 Genomic Health Revenue in Prostate Cancer Screening Business (2016-2021) 11.6.5 Genomic Health Recent Development 11.7 Mayo Clinic 11.7.1 Mayo Clinic Company Details 11.7.2 Mayo Clinic Business Overview 11.7.3 Mayo Clinic Prostate Cancer Screening Introduction 11.7.4 Mayo Clinic Revenue in Prostate Cancer Screening Business (2016-2021) 11.7.5 Mayo Clinic Recent Development 11.8 Mdxhealth 11.8.1 Mdxhealth Company Details 11.8.2 Mdxhealth Business Overview 11.8.3 Mdxhealth Prostate Cancer Screening Introduction 11.8.4 Mdxhealth Revenue in Prostate Cancer Screening Business (2016-2021) 11.8.5 Mdxhealth Recent Development 11.9 Roche Diagnostics 11.9.1 Roche Diagnostics Company Details 11.9.2 Roche Diagnostics Business Overview 11.9.3 Roche Diagnostics Prostate Cancer Screening Introduction 11.9.4 Roche Diagnostics Revenue in Prostate Cancer Screening Business (2016-2021) 11.9.5 Roche Diagnostics Recent Development 11.10 Rosetta Genomics 11.10.1 Rosetta Genomics Company Details 11.10.2 Rosetta Genomics Business Overview 11.10.3 Rosetta Genomics Prostate Cancer Screening Introduction 11.10.4 Rosetta Genomics Revenue in Prostate Cancer Screening Business (2016-2021) 11.10.5 Rosetta Genomics Recent Development 11.11 Thermo Fisher Scientific 11.11.1 Thermo Fisher Scientific Company Details 11.11.2 Thermo Fisher Scientific Business Overview 11.11.3 Thermo Fisher Scientific Prostate Cancer Screening Introduction 11.11.4 Thermo Fisher Scientific Revenue in Prostate Cancer Screening Business (2016-2021) 11.11.5 Thermo Fisher Scientific Recent Development 11.12 Hologic 11.12.1 Hologic Company Details 11.12.2 Hologic Business Overview 11.12.3 Hologic Prostate Cancer Screening Introduction 11.12.4 Hologic Revenue in Prostate Cancer Screening Business (2016-2021) 11.12.5 Hologic Recent Development 11.13 Myriad Genetics 11.13.1 Myriad Genetics Company Details 11.13.2 Myriad Genetics Business Overview 11.13.3 Myriad Genetics Prostate Cancer Screening Introduction 11.13.4 Myriad Genetics Revenue in Prostate Cancer Screening Business (2016-2021) 11.13.5 Myriad Genetics Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Prostate Cancer Screening Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Physical Exam Table 3. Key Players of Laboratory Tests Table 4. Key Players of Imaging Tests Table 5. Key Players of Gleason Score Table 6. Key Players of TNM Score Table 7. Key Players of Genetic Tests Table 8. Key Players of Digital Rectal Exam Table 9. Key Players of Biopsy Table 10. Global Prostate Cancer Screening Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 11. Global Prostate Cancer Screening Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 12. Global Prostate Cancer Screening Market Size by Regions (2016-2021) & (US$ Million) Table 13. Global Prostate Cancer Screening Market Share by Regions (2016-2021) Table 14. Global Prostate Cancer Screening Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 15. Global Prostate Cancer Screening Market Share by Regions (2022-2027) Table 16. Prostate Cancer Screening Market Trends Table 17. Prostate Cancer Screening Market Drivers Table 18. Prostate Cancer Screening Market Challenges Table 19. Prostate Cancer Screening Market Restraints Table 20. Global Prostate Cancer Screening Revenue by Players (2016-2021) & (US$ Million) Table 21. Global Prostate Cancer Screening Market Share by Players (2016-2021) Table 22. Global Top Prostate Cancer Screening Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Screening as of 2020) Table 23. Ranking of Global Top Prostate Cancer Screening Companies by Revenue (US$ Million) in 2020 Table 24. Global 5 Largest Players Market Share by Prostate Cancer Screening Revenue (CR5 and HHI) & (2016-2021) Table 25. Key Players Headquarters and Area Served Table 26. Key Players Prostate Cancer Screening Product Solution and Service Table 27. Date of Enter into Prostate Cancer Screening Market Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global Prostate Cancer Screening Market Size by Type (2016-2021) (US$ Million) Table 30. Global Prostate Cancer Screening Revenue Market Share by Type (2016-2021) Table 31. Global Prostate Cancer Screening Forecasted Market Size by Type (2022-2027) (US$ Million) Table 32. Global Prostate Cancer Screening Revenue Market Share by Type (2022-2027) & (US$ Million) Table 33. Global Prostate Cancer Screening Market Size Share by Application (2016-2021) & (US$ Million) Table 34. Global Prostate Cancer Screening Revenue Market Share by Application (2016-2021) Table 35. Global Prostate Cancer Screening Forecasted Market Size by Application (2022-2027) (US$ Million) Table 36. Global Prostate Cancer Screening Revenue Market Share by Application (2022-2027) & (US$ Million) Table 37. North America Prostate Cancer Screening Market Size by Type (2016-2021) (US$ Million) Table 38. North America Prostate Cancer Screening Market Size by Type (2022-2027) & (US$ Million) Table 39. North America Prostate Cancer Screening Market Size by Application (2016-2021) (US$ Million) Table 40. North America Prostate Cancer Screening Market Size by Application (2022-2027) & (US$ Million) Table 41. North America Prostate Cancer Screening Market Size by Country (2016-2021) & (US$ Million) Table 42. North America Prostate Cancer Screening Market Size by Country (2022-2027) & (US$ Million) Table 43. Europe Prostate Cancer Screening Market Size by Type (2016-2021) (US$ Million) Table 44. Europe Prostate Cancer Screening Market Size by Type (2022-2027) & (US$ Million) Table 45. Europe Prostate Cancer Screening Market Size by Application (2016-2021) (US$ Million) Table 46. Europe Prostate Cancer Screening Market Size by Application (2022-2027) & (US$ Million) Table 47. Europe Prostate Cancer Screening Market Size by Country (2016-2021) & (US$ Million) Table 48. Europe Prostate Cancer Screening Market Size by Country (2022-2027) & (US$ Million) Table 49. Asia-Pacific Prostate Cancer Screening Market Size by Type (2016-2021) (US$ Million) Table 50. Asia-Pacific Prostate Cancer Screening Market Size by Type (2022-2027) & (US$ Million) Table 51. Asia-Pacific Prostate Cancer Screening Market Size by Application (2016-2021) (US$ Million) Table 52. Asia-Pacific Prostate Cancer Screening Market Size by Application (2022-2027) & (US$ Million) Table 53. Asia-Pacific Prostate Cancer Screening Market Size by Region (2016-2021) & (US$ Million) Table 54. Asia-Pacific Prostate Cancer Screening Market Size by Region (2022-2027) & (US$ Million) Table 55. Latin America Prostate Cancer Screening Market Size by Type (2016-2021) (US$ Million) Table 56. Latin America Prostate Cancer Screening Market Size by Type (2022-2027) & (US$ Million) Table 57. Latin America Prostate Cancer Screening Market Size by Application (2016-2021) (US$ Million) Table 58. Latin America Prostate Cancer Screening Market Size by Application (2022-2027) & (US$ Million) Table 59. Latin America Prostate Cancer Screening Market Size by Country (2016-2021) & (US$ Million) Table 60. Latin America Prostate Cancer Screening Market Size by Country (2022-2027) & (US$ Million) Table 61. Middle East & Africa Prostate Cancer Screening Market Size by Type (2016-2021) (US$ Million) Table 62. Middle East & Africa Prostate Cancer Screening Market Size by Type (2022-2027) & (US$ Million) Table 63. Middle East & Africa Prostate Cancer Screening Market Size by Application (2016-2021) (US$ Million) Table 64. Middle East & Africa Prostate Cancer Screening Market Size by Application (2022-2027) & (US$ Million) Table 65. Middle East & Africa Prostate Cancer Screening Market Size by Country (2016-2021) & (US$ Million) Table 66. Middle East & Africa Prostate Cancer Screening Market Size by Country (2022-2027) & (US$ Million) Table 67. Abbott Laboratories Company Details Table 68. Abbott Laboratories Business Overview Table 69. Abbott Laboratories Prostate Cancer Screening Product Table 70. Abbott Laboratories Revenue in Prostate Cancer Screening Business (2016-2021) & (US$ Million) Table 71. Abbott Laboratories Recent Development Table 72. Almac Company Details Table 73. Almac Business Overview Table 74. Almac Prostate Cancer Screening Product Table 75. Almac Revenue in Prostate Cancer Screening Business (2016-2021) & (US$ Million) Table 76. Almac Recent Development Table 77. Bayer Company Details Table 78. Bayer Business Overview Table 79. Bayer Prostate Cancer Screening Product Table 80. Bayer Revenue in Prostate Cancer Screening Business (2016-2021) & (US$ Million) Table 81. Bayer Recent Development Table 82. Beckman Coulter Company Details Table 83. Beckman Coulter Business Overview Table 84. Beckman Coulter Prostate Cancer Screening Product Table 85. Beckman Coulter Revenue in Prostate Cancer Screening Business (2016-2021) & (US$ Million) Table 86. Beckman Coulter Recent Development Table 87. BioméRieux Company Details Table 88. BioméRieux Business Overview Table 89. BioméRieux Prostate Cancer Screening Product Table 90. BioméRieux Revenue in Prostate Cancer Screening Business (2016-2021) & (US$ Million) Table 91. BioméRieux Recent Development Table 92. Genomic Health Company Details Table 93. Genomic Health Business Overview Table 94. Genomic Health Prostate Cancer Screening Product Table 95. Genomic Health Revenue in Prostate Cancer Screening Business (2016-2021) & (US$ Million) Table 96. Genomic Health Recent Development Table 97. Mayo Clinic Company Details Table 98. Mayo Clinic Business Overview Table 99. Mayo Clinic Prostate Cancer Screening Product Table 100. Mayo Clinic Revenue in Prostate Cancer Screening Business (2016-2021) & (US$ Million) Table 101. Mayo Clinic Recent Development Table 102. Mdxhealth Company Details Table 103. Mdxhealth Business Overview Table 104. Mdxhealth Revenue in Prostate Cancer Screening Business (2016-2021) & (US$ Million) Table 105. Mdxhealth Recent Development Table 106. Roche Diagnostics Company Details Table 107. Roche Diagnostics Business Overview Table 108. Roche Diagnostics Prostate Cancer Screening Product Table 109. Roche Diagnostics Revenue in Prostate Cancer Screening Business (2016-2021) & (US$ Million) Table 110. Roche Diagnostics Recent Development Table 111. Rosetta Genomics Company Details Table 112. Rosetta Genomics Business Overview Table 113. Rosetta Genomics Prostate Cancer Screening Product Table 114. Rosetta Genomics Revenue in Prostate Cancer Screening Business (2016-2021) & (US$ Million) Table 115. Rosetta Genomics Recent Development Table 116. Thermo Fisher Scientific Company Details Table 117. Thermo Fisher Scientific Business Overview Table 118. Thermo Fisher Scientific Prostate Cancer Screening Product Table 119. Thermo Fisher Scientific Revenue in Prostate Cancer Screening Business (2016-2021) & (US$ Million) Table 120. Thermo Fisher Scientific Recent Development Table 121. Hologic Company Details Table 122. Hologic Business Overview Table 123. Hologic Prostate Cancer Screening Product Table 124. Hologic Revenue in Prostate Cancer Screening Business (2016-2021) & (US$ Million) Table 125. Hologic Recent Development Table 126. Myriad Genetics Company Details Table 127. Myriad Genetics Business Overview Table 128. Myriad Genetics Prostate Cancer Screening Product Table 129. Myriad Genetics Revenue in Prostate Cancer Screening Business (2016-2021) & (US$ Million) Table 130. Myriad Genetics Recent Development Table 131. Research Programs/Design for This Report Table 132. Key Data Information from Secondary Sources Table 133. Key Data Information from Primary Sources List of Figures Figure 1. Global Prostate Cancer Screening Market Share by Type: 2020 VS 2027 Figure 2. Physical Exam Features Figure 3. Laboratory Tests Features Figure 4. Imaging Tests Features Figure 5. Gleason Score Features Figure 6. TNM Score Features Figure 7. Genetic Tests Features Figure 8. Digital Rectal Exam Features Figure 9. Biopsy Features Figure 10. Global Prostate Cancer Screening Market Share by Application: 2020 VS 2027 Figure 11. Hospitals Case Studies Figure 12. Clinics Case Studies Figure 13. Research Labs Case Studies Figure 14. Cancer Institutes Case Studies Figure 15. Diagnostic Centers Case Studies Figure 16. Others Case Studies Figure 17. Prostate Cancer Screening Report Years Considered Figure 18. Global Prostate Cancer Screening Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 19. Global Prostate Cancer Screening Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 20. Global Prostate Cancer Screening Market Share by Regions: 2020 VS 2027 Figure 21. Global Prostate Cancer Screening Market Share by Regions (2022-2027) Figure 22. Global Prostate Cancer Screening Market Share by Players in 2020 Figure 23. Global Top Prostate Cancer Screening Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Screening as of 2020 Figure 24. The Top 10 and 5 Players Market Share by Prostate Cancer Screening Revenue in 2020 Figure 25. Global Prostate Cancer Screening Revenue Market Share by Type (2016-2021) Figure 26. Global Prostate Cancer Screening Revenue Market Share by Type (2022-2027) Figure 27. North America Prostate Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. North America Prostate Cancer Screening Market Share by Type (2016-2027) Figure 29. North America Prostate Cancer Screening Market Share by Application (2016-2027) Figure 30. North America Prostate Cancer Screening Market Share by Country (2016-2027) Figure 31. United States Prostate Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Canada Prostate Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Europe Prostate Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Europe Prostate Cancer Screening Market Share by Type (2016-2027) Figure 35. Europe Prostate Cancer Screening Market Share by Application (2016-2027) Figure 36. Europe Prostate Cancer Screening Market Share by Country (2016-2027) Figure 37. Germany Prostate Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. France Prostate Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. U.K. Prostate Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Italy Prostate Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Russia Prostate Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Nordic Prostate Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Asia-Pacific Prostate Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Asia-Pacific Prostate Cancer Screening Market Share by Type (2016-2027) Figure 45. Asia-Pacific Prostate Cancer Screening Market Share by Application (2016-2027) Figure 46. Asia-Pacific Prostate Cancer Screening Market Share by Region (2016-2027) Figure 47. China Prostate Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Japan Prostate Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. South Korea Prostate Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Southeast Asia Prostate Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. India Prostate Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Australia Prostate Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Latin America Prostate Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Latin America Prostate Cancer Screening Market Share by Type (2016-2027) Figure 55. Latin America Prostate Cancer Screening Market Share by Application (2016-2027) Figure 56. Latin America Prostate Cancer Screening Market Share by Country (2016-2027) Figure 57. Mexico Prostate Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Brazil Prostate Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Middle East & Africa Prostate Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Middle East & Africa Prostate Cancer Screening Market Share by Type (2016-2027) Figure 61. Middle East & Africa Prostate Cancer Screening Market Share by Application (2016-2027) Figure 62. Middle East & Africa Prostate Cancer Screening Market Share by Country (2016-2027) Figure 63. Turkey Prostate Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million) Figure 64. Saudi Arabia Prostate Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million) Figure 65. UAE Prostate Cancer Screening Market Size YoY Growth (2016-2027) & (US$ Million) Figure 66. Abbott Laboratories Revenue Growth Rate in Prostate Cancer Screening Business (2016-2021) Figure 67. Almac Revenue Growth Rate in Prostate Cancer Screening Business (2016-2021) Figure 68. Bayer Revenue Growth Rate in Prostate Cancer Screening Business (2016-2021) Figure 69. Beckman Coulter Revenue Growth Rate in Prostate Cancer Screening Business (2016-2021) Figure 70. BioméRieux Revenue Growth Rate in Prostate Cancer Screening Business (2016-2021) Figure 71. Genomic Health Revenue Growth Rate in Prostate Cancer Screening Business (2016-2021) Figure 72. Mayo Clinic Revenue Growth Rate in Prostate Cancer Screening Business (2016-2021) Figure 73. Mdxhealth Revenue Growth Rate in Prostate Cancer Screening Business (2016-2021) Figure 74. Roche Diagnostics Revenue Growth Rate in Prostate Cancer Screening Business (2016-2021) Figure 75. Rosetta Genomics Revenue Growth Rate in Prostate Cancer Screening Business (2016-2021) Figure 76. Thermo Fisher Scientific Revenue Growth Rate in Prostate Cancer Screening Business (2016-2021) Figure 77. Hologic Revenue Growth Rate in Prostate Cancer Screening Business (2016-2021) Figure 78. Myriad Genetics Revenue Growth Rate in Prostate Cancer Screening Business (2016-2021) Figure 79. Bottom-up and Top-down Approaches for This Report Figure 80. Data Triangulation Figure 81. Key Executives Interviewed

Abbott Laboratories Almac Bayer Beckman Coulter BioméRieux Genomic Health Mayo Clinic Mdxhealth Roche Diagnostics Rosetta Genomics Thermo Fisher Scientific Hologic Myriad Genetics